Cover image of the article: Gastrointestinal Stromal Tumors: Epidemiology and Treatment Outcomes

Image Credit:Int J Cancer Manag

Gastrointestinal Stromal Tumors: Epidemiology and Treatment Outcomes

Authors

Hassan Peyvandi1,*, E Haji Nasrollah2, SA Mousavian3, P Daryaii4, R Yeganeh2, A Davati5, GR Ghanei6
1Assistant professor of general surgery, Shahid Beheshti University (MC), Loghman Medical Center, Iran
2Associate professor of general surgery, Shahid Beheshti University (MC), Loghman Medical Center, Iran
3Resident of general surgery, Shahid Beheshti University (MC), Loghman Medical Center, Iran
4Assistant professor of general surgery, Tehran University of Medical Sciences, Cancer Institute, Iran
5Assistant professor of public medicine- Shahed Medical School, Iran
6Resident of general surgery, Tehran University of Medical Sciences, Sina Medical Center, Iran
*Corresponding Author: Corresponding author: Hassan Peyvandi, Assistant professor of general surgery, Shahid Beheshti University (MC), Loghman Medical Center, Iran, E-mail: Email: amir.mousavian@gmail.com

International Journal of Cancer Management:Vol. 2, issue 3; e80566
Published online:Sep 30, 2009
Article type:Research Article
Received:Sep 30, 2009
Accepted:Sep 30, 2009
How to Cite:Peyvandi H, Haji Nasrollah E, Mousavian S, Daryaii P, Yeganeh R, et al. Gastrointestinal Stromal Tumors: Epidemiology and Treatment Outcomes. Int J Cancer Manag. 2009;2(3):e80566. doi:

Abstract

Introduction: Numerous studies have investigated the prevalence, incidence and clinical manifestations of gastrointestinal stromal tumors (GISTs). However, little is known about GISTs in Iran. This pioneer study focuses on description of 36 patients with GISTs in Iran.

Methods: A database was created for 36 patients suffering from GIST who were treated in Loghman Medical Center and Tehran Cancer Institute in Tehran, Iran. Information on age, sex, clinical manifestations, treatment and outcomes were recorded and analyzed using SPSS version 13.

Results: Patients had an average age of 60 years; and 16 of them were males. The disease was most commonly manifested by abdominal mass, weight loss, and anemia. Twenty one patients had a mass smaller than 10cm; and in 33 patients KIT test was positive. In the follow-up, 5 patients experienced relapse and 3 succumbed due to advanced cancer.

Conclusion: Primary results showed that GISTs might have different manifestations and incidence in Iran compared to other parts of the world. We hope that this study could serve as a starting point for the better understanding and classification of this disease in Iran and for development of improved management strategies.

Highlights

Fulltext

The Full text is available in PDF.

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

5
Jul
2021
Multicentric Study of Clinicopathological Features of Primary Gastrointestinal Lymphoma of Iran: from 2011 - 2016

Multicentric Study of Clinicopathological Features of Primary Gastrointestinal Lymphoma of Iran: from 2011 - 2016

Farahnaz Bidarizerehpoosh,
Samira Ghasemi,
Arsham Moradi,
Afshin Moradi,
Behrang Kazeminezhad,
Elena Jamali
,et al.

Bidarizerehpoosh F, Ghasemi S, Moradi A, Moradi A, Kazeminezhad B, et al. Multicentric Study of Clinicopathological Features of Primary Gastrointestinal Lymphoma of Iran: from 2011 - 2016. Int J Cancer Manag. 2021;14(6):e97892. doi: https://doi.org/10.5812/ijcm.97892

30
Nov
2020
Urological Sarcoma Among the Iranian Population; A National Registry-Based Study

Urological Sarcoma Among the Iranian Population; A National Registry-Based Study

Mohammad Ali Ganji Jameshouran,
Farzad Allameh,
Mohammad Mersad Mansouri Tehrani,
Mohammad Ali Tasharrofi,
Babak Javanmard,
Morteza Fallah Karkan
,et al.

Ganji Jameshouran MA, Allameh F, Mansouri Tehrani MM, Tasharrofi MA, Javanmard B, et al. Urological Sarcoma Among the Iranian Population; A National Registry-Based Study. Int J Cancer Manag. 2020;13(12):e103700. doi: https://doi.org/10.5812/ijcm.103700

15
Jun
2021
Sarcomas Epidemiology in Iran: Analysis of Data from Iranian National Cancer Registry between 2009 and 2014

Sarcomas Epidemiology in Iran: Analysis of Data from Iranian National Cancer Registry between 2009 and 2014

Leila Asef-Kabiri,
Afshin Moradi,
Maryam Khayamzadeh,
Farid Moradian,
Mohammad Esmaeil Akbari

Asef-Kabiri L, Moradi A, Khayamzadeh M, Moradian F, Akbari ME. Sarcomas Epidemiology in Iran: Analysis of Data from Iranian National Cancer Registry between 2009 and 2014. Int J Cancer Manag. 2021;14(5):e110504. doi: https://doi.org/10.5812/ijcm.110504

30
Sep
2014
Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case

Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case

Amin Shafizad,
Mohammad Mohammadianpanah,
Hamid Nasrolahi,
Maral Mokhtari,
Seyed Abdolah Mousavi

Shafizad A, Mohammadianpanah M, Nasrolahi H, Mokhtari M, Mousavi SA. Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case. Int J Cancer Manag. 2014;7(3):e80549. doi:

31
Aug
2016
Incidence of Gastrointestinal Cancers in Iran: A Systematic Review

Incidence of Gastrointestinal Cancers in Iran: A Systematic Review

Kourosh Zarea,
Samira Beiranvand,
Saeed Ghanbari,
Hanna Tuvesson

Zarea K, Beiranvand S, Ghanbari S, Tuvesson H. Incidence of Gastrointestinal Cancers in Iran: A Systematic Review. Jundishapur J Chronic Dis Care. 2017;6(1):e37224. doi: https://doi.org/10.17795/jjcdc-37224

More by these authors

Hassan PeyvandiPubMedScholar
E Haji NasrollahPubMedScholar
SA MousavianPubMedScholar
P DaryaiiPubMedScholar
R YeganehPubMedScholar
GR GhaneiPubMedScholar
Share
Cited by
Metrics